Role of Sex Hormones in Human Body | IntechOpen
Clinical Research | Peer Reviewed | High Impact
Disruption by stealth - Interference of endocrine disrupting chemicals on hormonal crosstalk with thyroid axis function in humans and other animals - ScienceDirect
PDF) Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature
Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight - ScienceDirect
MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people in: European Journal of Endocrinology Volume 185 Issue 2 (2021)
Sex differences in biological aging with a focus on human studies | eLife
Growth hormone - Wikipedia
Hormone Molecular Biology and Clinical Investigation Template - De Gruyter
Cancers | Free Full-Text | The Landscape of CAR-T Cell Clinical Trials against Solid Tumors—A Comprehensive Overview
Joint adolescent–adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform—ACCELERATE - Annals of Oncology
pharmaceutical industry - Drug discovery and development | Britannica
Gender medicine and oncology: report and consensus of an ESMO workshop - Annals of Oncology
Molecular Biology Research Journal Impact factor List
Molecular and Cellular Biology Journal Homepage
![Discovery of 2-[3,5-Dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β Agonist in Clinical Trials for the Treatment of ...](https://pubs.acs.org/cms/10.1021/jm4019299/asset/images/jm4019299.social.jpeg_v03 "Discovery of 2-[3,5-Dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β Agonist in Clinical Trials for the Treatment of ...")
Discovery of 2-[3,5-Dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β Agonist in Clinical Trials for the Treatment of ...
Molecular enhancement of fracture healing - Is there a role for Bone Morphogenetic Protein-2, parathyroid hormone, statins, or sclerostin-antibodies? - Injury
Hormone Molecular Biology and Clinical Investigation Template - De Gruyter
Metabolic liver disease in diabetes – From mechanisms to clinical trials - Metabolism - Clinical and Experimental
Breast Cancer Biology: Clinical Implications for Breast Radiation Therapy - International Journal of Radiation Oncology, Biology, Physics
Chrousos syndrome: from molecular pathogenesis to therapeutic management - Nicolaides - 2015 - European Journal of Clinical Investigation - Wiley Online Library
Clinical Trials Based on Mesenchymal Stromal Cells are Exponentially Increasing: Where are We in Recent Years? | SpringerLink
